LawrenceJ.SingermanMDFACS

Ophthalmology • Beachwood, OH

Retinal Disease, Uveitis

Professor of Clinical Ophthalmology Case Western Reserve University and Bascom Palmer Eye Institute

Join to view full profile

Dr. Singerman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Singerman's full profile

Already have an account?

Office
24075 Commerce Park
Beachwood, OH 44122
Phone+1 216-831-5700

Fax+1 216-831-1959

Education & Training

Johns Hopkins UniversityFellowship, Surgical Retina and Vitreous, 1973 - 1974
Mount Sinai Medical Center of ClevelandResidency, Ophthalmology, 1970 - 1973
Mount Sinai Medical Center of ClevelandInternship, Transitional Year, 1969 - 1970
Wayne State University School of MedicineClass of 1969

Certifications & Licensure

MI State Medical License 1970 - Present
FL State Medical License 2008 - 2027
OH State Medical License 1970 - 2026
PA State Medical License 2008 - 2024
CT State Medical License 2008 - 2009
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Top MD Consumers Checkbook
Fellow (FACS) American College of Surgeons
Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion Start of enrollment: 2009 Nov 01
Unknown status
Phase 1
Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Start of enrollment: 2011 Oct 01
Completed
Phase 3
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
COMPLETED
PHASE2
Phase II Combination Steroid and Anti-VEGF for Persistent DME Start of enrollment: 2014 Feb 01
Completed
Phase 2
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD Start of enrollment: 2015 Jul 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

10 citations
Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular d...
Joseph M Coney, Ryan Zubricky, Samriddhi Buxy Sinha, Nina Sonbolian, Lujia Zhou
International Journal of Retina and Vitreous. 2023-02-01
One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents.
Joseph M Coney, Jasmyne E McCoy, Samriddhi Buxy Sinha, Nina Sonbolian, Lujia Zhou
Clinical Ophthalmology. 2023-01-01
16 citations
A Smart Mobile Application to Monitor Visual Function in Diabetic Retinopathy and Age-Related Macular Degeneration: The CLEAR Study.
Rahul N. Khurana, Carol Hoang, Arshad M. Khanani, Nikolai Steklov, Lawrence J. Singerman
American Journal of Ophthalmology. 2021-04-05

Press Mentions

Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Angiogenesis 2019 Session III: High Risk Non-Exudative AMDFebruary 12th, 2019
Bascom Palmer Eye InstituteFebruary 9th, 2019

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow
American College of Surgeons - ACS
Member

External Links

Websitehttp://www.retina-doctors.com